Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +46.08%
#3 Glidr Glidr +45.16%
#4 Cysic Cysic +32.50%
#5 Tutorial Tutorial +24.70%
#6 Walrus Walrus +24.17%
#7 Humanity Humanity +17.87%
#8 Enso Enso +17.09%
#9 Codatta Codatta +14.33%
#10 Huma Finance Huma Finance +14.16%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Classement en actions #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Prix de l'action
$0.069
Dernière synchronisation: 2024-07-22
Capitalisation boursière
$2.06M
Changement (1 jour)
-1.43%
Changement (1 an)
0.00%
Pays
US
Échange DermTech, Inc. (DMTK)

Catégorie

Healthcare
Revenus pour DermTech, Inc. (DMTK)
Revenus en Mar 2024 TTM : $15.66M
Selon les derniers rapports financiers de DermTech, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $15.66M. En 2022, l'entreprise a réalisé un chiffre d'affaires de $14.52M une augmentation par rapport à le chiffre d'affaires de l'année 2021, qui était de $11.84M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour DermTech, Inc. de 2012 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $15.66M 2.41%
2023 $15.30M 5.36%
2022 $14.52M 22.64%
2021 $11.84M 101.16%
2020 $5.89M 74.94%
2019 $3.36M 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 295,712.05%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 160,184.73%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 17,182.16%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 28,968.07%
US